NASDAQ:ALECAlector Stock Price, Forecast & News

Alector's stock was trading at $24.92 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALEC stock has decreased by 11.9% and is now trading at $21.96. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alector.

Alector is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Alector.

Alector Inc (NASDAQ:ALEC) announced its earnings results on Wednesday, May, 13th. The company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.10. The business had revenue of $7.17 million for the quarter, compared to analyst estimates of $10.60 million. Alector had a negative net margin of 556.70% and a negative return on equity of 48.29%. View Alector's earnings history.

8 equities research analysts have issued twelve-month price targets for Alector's stock. Their forecasts range from $28.00 to $41.00. On average, they expect Alector's stock price to reach $33.00 in the next twelve months. This suggests a possible upside of 50.3% from the stock's current price. View analysts' price targets for Alector.

Press coverage about ALEC stock has been trending somewhat negative on Thursday, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Alector earned a news impact score of -1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Alector.

Alector saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 5,760,000 shares, an increase of 11.6% from the June 15th total of 5,160,000 shares. Based on an average daily volume of 492,100 shares, the short-interest ratio is currently 11.7 days. Currently, 11.1% of the shares of the company are sold short. View Alector's Current Options Chain.

Some companies that are related to Alector include Repligen (RGEN), Novavax (NVAX), Crispr Therapeutics (CRSP), Acceleron Pharma (XLRN), Allogene Therapeutics (ALLO), Adaptive Biotechnologies (ADPT), Spark Therapeutics (ONCE), China Biologic Products (CBPO), Momenta Pharmaceuticals (MNTA), Halozyme Therapeutics (HALO), Ablynx (ABLYF), Iovance Biotherapeutics (IOVA), bluebird bio (BLUE), Denali Therapeutics (DNLI) and Fate Therapeutics (FATE). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Cisco Systems (CSCO), Harpoon Therapeutics (HARP), Johnson & Johnson (JNJ), Kaleido Biosciences (KLDO) and AT&T (T).

(ALEC) raised $177 million in an initial public offering (IPO) on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALEC stock can currently be purchased for approximately $21.96.

Alector has a market capitalization of $1.74 billion and generates $21.22 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Alector employs 91 workers across the globe.

The official website for Alector is www.alector.com.

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]